Annexon (ANNX) Expected to Announce Quarterly Earnings on Monday

Annexon (NASDAQ:ANNX - Get Free Report) will likely be announcing its Q1 2025 earnings results before the market opens on Monday, May 12th. Analysts expect Annexon to post earnings of ($0.30) per share for the quarter.

Annexon (NASDAQ:ANNX - Get Free Report) last released its earnings results on Monday, March 3rd. The company reported ($0.33) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.28) by ($0.05). On average, analysts expect Annexon to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Annexon Stock Performance

Shares of NASDAQ:ANNX traded up $0.05 during midday trading on Wednesday, hitting $1.69. 976,109 shares of the stock were exchanged, compared to its average volume of 1,794,549. The business's fifty day simple moving average is $2.03 and its two-hundred day simple moving average is $3.95. Annexon has a 52-week low of $1.29 and a 52-week high of $7.85. The company has a market capitalization of $185.42 million, a PE ratio of -1.61 and a beta of 1.24.

Wall Street Analyst Weigh In

Separately, Needham & Company LLC reaffirmed a "buy" rating and set a $16.00 target price on shares of Annexon in a research report on Tuesday, March 4th.

About Annexon

Annexon, Inc, a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. Its lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase II clinical trial for the treatment of amyotrophic lateral sclerosis.